Scientists Feel India Should Introduce HTA

After attending the 5th Asia Pacific Conference of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) at Taipei in […]

European IT project to detect adverse drug reactions underway

A project, recently approved by the EU, aims to exploit data from electronic healthcare records (EHRs) and biomedical databases to foster the early detection of adverse drug reactions (ADRs).

Accenture and ICRI enter strategic partnership, launch programme in Pharmacovigilance

Accenture and the Institute of Clinical Research in India (ICRI) had announced jointly to develop a Pharmacovigilance and clinical research programme customised to meet the growing industry requirements of the thriving sector.

The Elusive Culture of Compliance : Ajit Nigam, Business Development Manager, Relsys India Private Ltd.

[This article was published in the August 2008 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]

The demand for a medicinal product brings with it the issues of Safety and Efficacy. Regulators can play a pivotal role in monitoring the medicinal

Lilly’s CEO Calls for Reform of US Drug Safety System

Sidney Taurel, CEO, Eli Lilly and Company called on the health care industry, medical community and U.S. government to work on a health information technology system to provide rapid and useful insights on the effectiveness of medicines while improving drug safety.

First ‘pharmacovigilance’ center launched in India

Accenture and the Bristol-Myers Squibb Company have together launched the pharmaceutical industry’s first ‘pharmacovigilance’ center, in Chennai, India, to monitor safety of data collected on medicines.